Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD Journal of Pain and Symptom Management Volume 39, Issue 6, Pages e4-e6 (June 2010) DOI: 10.1016/j.jpainsymman.2010.02.003 Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions
Fig. 1 Incidence (%) of OM, median intensity of OM pain (VAS score 0-10) on individual day posttransplant (0=day of stem cell transplantation), and median day of TB treatment start. Journal of Pain and Symptom Management 2010 39, e4-e6DOI: (10.1016/j.jpainsymman.2010.02.003) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions